1-4 of 4
Hisayuki Yokoyama, PhD
Close
Sort by
Journal Articles

Bortezomib Enhances the Antitumor Activity of Adoptively Infused Natural Killer Cells In Vivo: A Novel Approach To Override KIR-Mediated Inhibition of NK Cell Cytotoxicity.

Andreas Lundqvist, PhD, Sheila Rao, BS, Aleah Smith, BS, Maria Berg, BS, Su Su, PhD, Hisayuki Yokoyama, PhD, Shivani Srivastava, MD, Richard Childs, MD
Journal: Blood
Blood (2007) 110 (11): 1786.
https://doi.org/10.1182/blood.V110.11.1786.1786
Published: 2007
Journal Articles

The Proteasome Inhibitor Bortezomib Simultaneously Enhances NK Cell Tumor Cytotoxicity While Paradoxically Reducing Antigen Specific T-Cell Tumor Cytotoxicity.

Andreas Lundqvist, PhD, Sheila Rao, BS, Maria Berg, BS, Aleah Smith, BS, Su Su, PhD, Hisayuki Yokoyama, PhD, Shivani Srivastava, MD, Richard Childs, MD
Journal: Blood
Blood (2007) 110 (11): 1789.
https://doi.org/10.1182/blood.V110.11.1789.1789
Published: 2007
Journal Articles

Adoptive Infusion of Alloreactive Donor NK Cells Reduces GVHD, Mediates Anti-Tumor Effects and Prolongs Survival in Recipients of MHC-Matched Hematopoietic Cell Transplantation.

Andreas Lundqvist, PhD, Philip McCoy, PhD, Leigh Samsel, MS, Aleah Smith, MS, Shivani Srivastava, MD, Nanae Harashima, PhD, Hisayuki Yokoyama, PhD, Maria Berg, MS, Richard Childs, MD
Journal: Blood
Blood (2006) 108 (11): 3233.
https://doi.org/10.1182/blood.V108.11.3233.3233
Published: 2006
Journal Articles

In Vitro and In Vivo Sensitization of Malignant Cells to Autologous Natural Killer Cell Cytotoxicity Following Exposure to Bortezomib.

Andreas Lundqvist, PhD, Kristy Greeneltch, PhD, Maria Berg, MS, Shivani Srivastava, MD, Nanae Harashima, PhD, Hisayuki Yokoyama, PhD, Aleah Smith, MS, Scott Abrams, PhD, Richard Childs, MD
Journal: Blood
Blood (2006) 108 (11): 925.
https://doi.org/10.1182/blood.V108.11.925.925
Published: 2006